Dialysis Corp. of America (DCAI) Approves $3M Buyback

April 13, 2009 10:47 AM EDT

Dialysis Corporation of America (Nasdaq: DCAI) announced that its Board of Directors has approved a stock repurchase program, effective April 13, 2009. Under the program, the company is authorized to repurchase up to $3 million of its outstanding shares of common stock from time to time, depending on market conditions, share price and other factors.

The stock purchases will be made out of available cash in open market transactions at the prevailing market price or through privately negotiated transactions.


Related Categories

Stock Buybacks

Stocks Mentioned

DCAI 7.29

-0.02 -0.27%
Volume: 8,160
Track DCAI


Add Your Comment